BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24423922)

  • 1. The impact of organisational external peer review on colorectal cancer treatment and survival in the Netherlands.
    Kilsdonk MJ; van Dijk BA; Otter R; Siesling S; van Harten WH
    Br J Cancer; 2014 Feb; 110(4):850-8. PubMed ID: 24423922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional variation in breast cancer treatment in the Netherlands and the role of external peer review: a cohort study comprising 63,516 women.
    Kilsdonk MJ; van Dijk BA; Otter R; van Harten WH; Siesling S
    BMC Cancer; 2014 Aug; 14():596. PubMed ID: 25129126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study.
    Zanders MM; van Steenbergen LN; Haak HR; Rutten HJ; Pruijt JF; Poortmans PM; Lemmens VE; van de Poll-Franse LV
    Diabet Med; 2013 Oct; 30(10):1181-8. PubMed ID: 23758334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands.
    Elferink MA; Krijnen P; Wouters MW; Lemmens VE; Jansen-Landheer ML; van de Velde CJ; Langendijk JA; Marijnen CA; Siesling S; Tollenaar RA
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S74-82. PubMed ID: 20598844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials].
    Lamberti C; Lundin S; Bogdanow M; Gorschlüter M; Schmidt-Wolf IG; Sauerbruch T
    Dtsch Med Wochenschr; 2006 Mar; 131(10):485-90. PubMed ID: 16511737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Peer Support on Colorectal Cancer Patients' Adherence to Guideline-Concordant Multidisciplinary Care.
    Kanters AE; Morris AM; Abrahamse PH; Mody L; Suwanabol PA
    Dis Colon Rectum; 2018 Jul; 61(7):817-823. PubMed ID: 29771795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two decades of external peer review of cancer care in general hospitals; the Dutch experience.
    Kilsdonk MJ; Siesling S; Otter R; van Harten WH
    Cancer Med; 2016 Mar; 5(3):478-85. PubMed ID: 26714788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
    Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
    BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity.
    Lemmens VE; van Halteren AH; Janssen-Heijnen ML; Vreugdenhil G; Repelaer van Driel OJ; Coebergh JW
    Ann Oncol; 2005 May; 16(5):767-72. PubMed ID: 15817594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No difference between lowest and highest volume hospitals in outcome after colorectal cancer surgery in the southern Netherlands.
    van Erning FN; van Steenbergen LN; van den Broek WT; Rutten HJ; Lemmens VE
    Eur J Surg Oncol; 2013 Nov; 39(11):1199-206. PubMed ID: 24044806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of interhospital variation in adjuvant chemotherapy for patients with Stage II/III colorectal cancer: a nationwide study.
    Arakawa K; Kawai K; Tanaka T; Hata K; Sugihara K; Nozawa H
    Colorectal Dis; 2018 Jul; 20(7):O162-O172. PubMed ID: 29752849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of guideline-recommended adjuvant therapies and survival outcomes for people with colorectal cancer at tertiary referral hospitals in South Australia.
    Adelson P; Fusco K; Karapetis C; Wattchow D; Joshi R; Price T; Sharplin G; Roder D
    J Eval Clin Pract; 2018 Feb; 24(1):135-144. PubMed ID: 28474459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No Difference in Overall Survival Between Hospital Volumes for Patients With Colorectal Cancer in The Netherlands.
    Bos AC; van Erning FN; Elferink MA; Rutten HJ; van Oijen MG; de Wilt JH; Lemmens VE
    Dis Colon Rectum; 2016 Oct; 59(10):943-52. PubMed ID: 27602925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative Outcomes of Screen-Detected vs Non-Screen-Detected Colorectal Cancer in the Netherlands.
    de Neree Tot Babberich MPM; Vermeer NCA; Wouters MWJM; van Grevenstein WMU; Peeters KCMJ; Dekker E; Tanis PJ;
    JAMA Surg; 2018 Dec; 153(12):e183567. PubMed ID: 30285063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Dose-Escalated Chemoradiation on Complete Tumor Response in Patients with Locally Advanced Rectal Cancer (RECTAL-BOOST): A Phase 2 Randomized Controlled Trial.
    Couwenberg AM; Burbach JPM; Berbee M; Lacle MM; Arensman R; Raicu MG; Wessels FJ; Verdult J; Roodhart J; Reerink O; Hoendervangers S; Buijsen J; Grabsch HI; Pronk A; Consten ECJ; Smits AB; Heikens JT; Appelt AL; van Grevenstein WMU; Verkooijen HM; Intven MPW
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1008-1018. PubMed ID: 32565319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.
    Breugom AJ; van Gijn W; Muller EW; Berglund Å; van den Broek CBM; Fokstuen T; Gelderblom H; Kapiteijn E; Leer JWH; Marijnen CAM; Martijn H; Meershoek-Klein Kranenbarg E; Nagtegaal ID; Påhlman L; Punt CJA; Putter H; Roodvoets AGH; Rutten HJT; Steup WH; Glimelius B; van de Velde CJH
    Ann Oncol; 2015 Apr; 26(4):696-701. PubMed ID: 25480874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE high resolution study.
    Gatta G; Zigon G; Aareleid T; Ardanaz E; Bielska-Lasota M; Galceran J; Góźdź S; Hakulinen T; Martinez-Garcia C; Plesko I; Zakelj MP; Rachtan J; Tagliabue G; Vercelli M; Faivre J
    Acta Oncol; 2010 Aug; 49(6):776-83. PubMed ID: 20429733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.
    Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH
    Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of kidney function on colorectal cancer patients with localized and regional diseases: An observational study from Taiwan.
    Chiang SF; Chen JS; Tang R; Yeh CY; Hsieh PS; Tsai WS; You JF; Hung HY; Lai CC; Lin JR; Chiang JM
    Indian J Cancer; 2019; 56(3):241-247. PubMed ID: 31389388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.